Structured Review

Novartis i deleu reports clinical trial funding
I Deleu Reports Clinical Trial Funding, supplied by Novartis, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/i deleu reports clinical trial funding/product/Novartis
Average 85 stars, based on 1 article reviews
Price from $9.99 to $1999.99
i deleu reports clinical trial funding - by Bioz Stars, 2020-09
85/100 stars

Images

Related Articles

other:

Article Title: Everolimus plus exemestane as first-line therapy in HR+, HER2− advanced breast cancer in BOLERO-2
Article Snippet: I. Deleu reports clinical trial funding from Novartis.

Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 85
    Novartis i deleu reports clinical trial funding
    I Deleu Reports Clinical Trial Funding, supplied by Novartis, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/i deleu reports clinical trial funding/product/Novartis
    Average 85 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    i deleu reports clinical trial funding - by Bioz Stars, 2020-09
    85/100 stars
      Buy from Supplier

    Image Search Results